Health
Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada – Motley Fool Australia
Health Canada will determine BNT162b2’s suitability for approval as clinical trial data comes in.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The coronavirus vaccine candidate being developed by Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country’s healthcare regulatory authority.
A rolling review is one undertaken while a candidate is still in developme…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General22 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Noosa News12 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?